Yes. Thanks, Mr. Chairman.
I thought it would be helpful for us to review what the committee had recently studied, so I went through the briefing book.
Starting in June 2015, we studied lung cancer in Canada. Mental health in Canada was studied in May 2015. “Health Canada Safety Code 6” was looked at in March 2015. In 2014-2015 the committee studied “Best Practices and Federal Barriers: Practice and Training of Healthcare Professionals”. There was a statutory review of the Pest Control Products Act in January 2015. E-cigarettes were studied in late 2014. There was a study of marijuana's health risks and harms in May and October 2014. Government's role in addressing prescription drug abuse was in 2013-2014. We looked at technological innovation in health care in 2012-2013. In October 2012 the committee studied vaccine priority lists during pandemics, and in March 2012, neurological diseases. We looked at the role of government and industry in determining drug supply in Canada in March to June of 2012. Finally, there was a study of chronic diseases related to aging and health promotion and disease prevention in 2011-2012.
I just thought it would be helpful for us to know what had been studied. This was triggered by Sonia's reference to mental health. I agree it's an important thing, but it was just studied by the committee, so we may not want to—